Citation: Gm. Podsakoff, Lentiviral vectors approach the clinical but fall back: National Institutes of Health Recombinant DNA Advisory Committee review of a first clinical protocol for use of a lentiviral vector, MOL THER, 4(4), 2001, pp. 282-283
Authors:
Brockstedt, DG
Podsakoff, GM
Fong, L
Kurtzman, G
Mueller-Ruchholtz, W
Engleman, EG
Citation: Dg. Brockstedt et al., Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration, CLIN IMMUNO, 92(1), 1999, pp. 67-75
Authors:
Herzog, RW
Yang, EY
Couto, LB
Hagstrom, JN
Elwell, D
Fields, PA
Burton, M
Bellinger, DA
Read, MS
Brinkhous, KM
Podsakoff, GM
Nichols, TC
Kurtzman, GJ
High, KA
Citation: Rw. Herzog et al., Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector, NAT MED, 5(1), 1999, pp. 56-63
Authors:
Watson, GL
Sayles, JN
Chen, C
Elliger, SS
Elliger, CA
Raju, NR
Kurtzman, GJ
Podsakoff, GM
Citation: Gl. Watson et al., Treatment of lysosomal storage disease in MPS VII mice using a recombinantadeno-associated virus, GENE THER, 5(12), 1998, pp. 1642-1649